Airway obstruction and bronchial reactivity from age 1 month until 13 years in children with asthma: A prospective birth cohort study

 

PLoS Med 16(1): e1002722. https://doi.org/10.1371/journal.pmed.1002722

Henrik Wegener Hallas, Bo Lund Chawes, Morten Arendt Rasmussen, Lambang Arianto, Jakob Stokholm, Klaus Bønnelykke, Hans Bisgaard

Investigators assessed 411 children from the at-risk COPSAC2000 birth cohort born to mothers with asthma to examine if low lung function and bronchial hyperreactivity are inherent features that increase the risk of developing airway inflammation and asthmatic symptoms. They observed that children who developed asthma had decreased lung function from 1 month of age throughout childhood as vs children without asthma. This lung function characteristic was evident prior to the development of airway inflammation and asthma, and did not worsen with prolonged duration of asthma symptoms. Findings, therefore, suggested that airway obstruction and bronchial hyperreactivity may be stable traits of childhood asthma, indicating that symptomatic disease may be a result of these traits but not their cause.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: World Health Organization releases guidelines for digital health adoption | MobiHealthNews… https://t.co/6DcfNz3h2R
5hreplyretweetfavorite
Interasma RT @worldallergy: WAO and the French Allergy Society (SFA) invite you to submit an abstract for the World Allergy Congress 2019 that will b…
14hreplyretweetfavorite
Interasma RT @Aller_MD: “Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wh…
14hreplyretweetfavorite
Interasma RT @Aller_MD: “Lentiviral vector gene therapy with low-exposure, targeted busulfan in infants with newly diagnosed SCID-X1 resulted in mult…
14hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma